Viewing Study NCT04689308

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2026-02-07 @ 1:49 PM
Study NCT ID: NCT04689308
Status: UNKNOWN
Last Update Posted: 2021-09-08
First Post: 2020-12-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell Malignancies
Sponsor: Minghui Pharmaceutical (Shanghai) LTD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed/Refractory B-cell Malignancies View
Keywords: